Active, not recruiting
Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis
NCT04754945
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- University of California Orange, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Karmanos Cancer Institute Detroit, Michigan, United States